
Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS® trials
Keywords: ظرفیت حیاتی اجباری; Forced vital capacity; Acute exacerbations; Disease progression; Quality of life; Mortality; bid; twice daily; FGFR; fibroblast growth factor receptor; FVC; forced vital capacity; HR; hazard ratio; IPF; idiopathic pulmonary fibrosis; MedDRA; Medical Dicti